SCHEMBL6653148

SCHEMBL6653148

CNC(=O)/C(C#N)=C/c1ccc(O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.65
CYP3A4 P08684 2/20 0.65
HPGD P15428 2/20 0.65
CISD1 Q9NZ45 2/20 0.65
KDM4E B2RXH2 1/20 0.65
SLC16A3 O15427 1/20 0.65
SLC16A1 P53985 1/20 0.65
GPR35 Q9HC97 1/20 0.65
MEN1 O00255 4/20 0.62
KMT2A Q03164 4/20 0.62
HSP90AA1 P07900 1/20 0.57
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
ATM Q13315 1/20 0.53
EGFR P00533 2/20 0.53
CYP1A2 P05177 1/20 0.53
PKM P14618 1/20 0.53
TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6653154 1.00 ALDH1A1 (0.65) ALDH1A1CYP3A4HPGDCISD1KDM4E
SCHEMBL30645352 0.85 ATM (0.70) ALDH1A1HPGDKDM4EMEN1KMT2A
SCHEMBL801207 0.81 ALDH1A1 (0.71) ALDH1A1CYP3A4HPGDCISD1KDM4E
SCHEMBL13400584 0.81 MEN1 (0.68) ALDH1A1CYP3A4HPGDCISD1KDM4E
SCHEMBL782201 0.80 ALDH1A1 (0.65) ALDH1A1CYP3A4HPGDCISD1KDM4E
SCHEMBL13376833 0.80 ALDH1A1 (0.65) ALDH1A1CYP3A4HPGDCISD1KDM4E
SCHEMBL782202 0.80 ALDH1A1 (0.65) ALDH1A1CYP3A4HPGDCISD1KDM4E
SCHEMBL13060204 0.80 ALDH1A1 (0.74) ALDH1A1CYP3A4HPGDCISD1KDM4E
SCHEMBL5950161 0.79 MEN1 (0.71) ALDH1A1MEN1KMT2AMAPK1BLM
SCHEMBL5950156 0.79 MEN1 (0.71) ALDH1A1MEN1KMT2AMAPK1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040254241-A1 Enzyme inhibitor; cognition activators KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-12-16 US disclosed
EP-1431280-A1 ARYL SULFAMATE DERIVATIVES Kyowa Hakko Kogyo Co., Ltd (JP) 2004-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254241-A1 Enzyme inhibitor; cognition activators SULT1A1, STS, CYP26A1 ALDH1A1 1187/4885CYP3A4 208/4885HPGD 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.